COMP <GO>
WAT vs UNH // 10Y YIELD & FRED MACRO BETA
Waters Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: WAT 8
— UNH 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: WAT
LAST: $462.72 (-3.61%) • MKT CAP: $47.17B
macro-sensitivity
1.02
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WAT VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WAT | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.30% | 88.57% | -29.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | 11.47% | +5.33 | WAT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 51.5x | 16.4x | +35.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 1.08% | 6.48% | -5.40 | UNH | /fcf-yield <GO> |
| Operating Margin | 25.40% | 4.82% | +20.58 | WAT | /operating-margins <GO> |
| Net Profit Margin | 20.30% | 3.14% | +17.16 | WAT | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | 6.46% | +0.54 | WAT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 15.49 | 3.12 | +12.37 | WAT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | WAT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.74% | +0.26 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.9 | 56.0 | +3.83 | WAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.02 | 0.33 | +0.69 | WAT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 68.3x | 17.1x | +51.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $47.17B | $364.66B | -$317.49B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WAT REV | UNH REV | WAT GROSS % | UNH GROSS % | WAT FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.17B | $447.57B | 59.3% | 88.7% | $510.1M | $16.07B |
| FY 2024 | $2.96B | $400.28B | 59.4% | 88.3% | $629.0M | $20.70B |
| FY 2023 | $2.96B | $371.62B | 44.0% | 89.6% | $469.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WAT // BETA 1.02
UNH // BETA 0.33